Iovance Biotherapeutics
Mauricio Buitrago has an extensive background in analytics and forecasting, with experience in various leadership roles at companies such as Iovance Biotherapeutics, Claritas Rx, Gilead Sciences, and ZS Associates. Before entering the healthcare industry, Mauricio gained experience in industrial engineering and project management at companies like Bechtel and Advanced MicroDevices. Mauricio holds an MBA from the University of California, Berkeley, along with a MS in Industrial Engineering and Operations Research and a Certificate in Management of Technology from the same institution. Additionally, Mauricio holds a BS in Industrial and Systems Engineering from the University of Florida and attended Pontificia Universidad Javeriana for their early education.
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.